POST-COVID-19 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
Clinical trials for POST-COVID-19 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POST-COVID-19 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME trials appear
Sign up with your email to follow new studies for POST-COVID-19 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple pill tame long COVID's immune chaos?
Disease control Recruiting nowThis phase 2 trial tests whether a drug called 2-HOBA can reduce immune system overactivity in people with Long COVID who also have POTS (a condition causing rapid heart rate upon standing). The study will enroll 50 participants and randomly assign them to receive either 2-HOBA o…
Matched conditions: POST-COVID-19 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a frayed nerve explain long COVID symptoms? new study investigates
Knowledge-focused Recruiting nowThis study looks at why some people develop POTS (a condition causing rapid heartbeat and dizziness) after COVID-19. Researchers think a part of the nervous system that normally fights inflammation may not work well in these patients. They will compare 150 adults with and without…
Matched conditions: POST-COVID-19 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC